Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-06-01Clinical Trial Update: The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis Disorder
The University of British Columbia is conducting a study to establish a biobank and database of genetic polymorphisms and their associations…
-
CLINICAL_TRIALS research · 2016-06-01Clinical Trial Update: Adverse Events and Genomics in Schizophrenia
An update on a schizophrenia genomics study focusing on adverse events associated with antipsychotics, sponsored by the University of Britis…
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS) [NA]
Update on the PECANS study, a pan-European trial evaluating antipsychotic-naive patients with schizophrenia.
-
CLINICAL_TRIALS research · 2016-05-25Clinical Trial Update: The Music Study in Refractory Psychosis
This entry is an update on a clinical trial called The Music Study in Refractory Psychosis, sponsored by the University of British Columbia.…
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics
The trial evaluating hospitalization rates in people with schizophrenia treated with antipsychotics has completed. No specific results are p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-05-18FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for HALOPERIDOL DECANOATE by Patriot Pharmaceuticals LLC, updating the product's approval status.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125) [Phase 3]
Long-term extension Phase III trial of asenapine in schizophrenia completed; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia [Phase 2]
Phase 2 trial evaluating AVE1625 as a co-treatment with antipsychotic therapy for schizophrenia has been terminated.
-
FDA approval · 2016-05-17FDA Approved: QUETIAPINE FUMARATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for a generic version of quetiapine fumarate by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Aripiprazole Once-monthly in Patients With Schizophrenia [Phase 3]
Phase 3 clinical trial update showing results for aripiprazole once-monthly in adults with schizophrenia; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia [Phase 1, Phase 2]
The document reports the completion of a randomized Phase 1/2 trial studying intensive computer-based cognitive remediation in individuals w…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Genes, Intermediate Phenotypes and Response to Quetiapine RX
A completed clinical trial investigating how genes and intermediate phenotypes relate to response to quetiapine in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Glutamate, Learning, and Working Memory [Phase 1]
A Phase 1 UCLA clinical trial investigating how glutamate influences learning and working memory in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Single Ascending Dose Study of RBP-7000 [Phase 1]
Phase 1 single ascending dose study of RBP-7000 in schizophrenia completed; results are not detailed in the snippet provided.
-
FDA approval · 2016-05-06FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc., indicating approved changes to t…
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: First in Man Study of Safety, Tolerability and PK Profile of RBP-7000 [Phase 1]
First-in-man Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of RBP-7000 in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy [Phase 3]
Phase 3 trial evaluating EVP-6124 as an adjunct pro-cognitive treatment in schizophrenia patients on stable antipsychotic therapy has comple…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy [Phase 3]
Reports results of a 26-week extension study of EVP-6124 (encenicline), an alpha-7 nicotinic receptor agonist, as adjunctive pro-cognitive t…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy [Phase 3]
This update covers a Phase 3 trial of EVP-6124 (encenicline), an alpha-7 nicotinic receptor agonist, used as adjunctive pro-cognitive therap…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia [Phase 3]
This Phase 3 clinical trial update reports results for the paliperidone palmitate 3-month and 1-month formulations in schizophrenia. Results…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities [Phase 4]
Phase 4 trial evaluating adjunctive low-dose metformin in patients with schizophrenia and metabolic abnormalities (metabolic syndrome) has c…
-
FDA approval · 2016-04-25FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (Mylan Pharmaceuticals Inc.). This action updates t…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Remediation of Working Memory in Schizophrenia [NA]
A completed clinical trial evaluating remediation of working memory in schizophrenia and schizoaffective disorder, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize... [NA]
This clinical trial update reports the completed efficacy evaluation of two metacognitive training modules (Jumping to Conclusions and To Em…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Improving Basic and Social Cognition in Veterans With Schizophrenia [NA]
This clinical trial update describes a study aimed at improving basic and social cognition in veterans with schizophrenia or schizoaffective…